K
KVACU
FinancialsKeen Vision Acquisition Corporation Units
—
+0.00%
Live · NASDAQ · Mar 28, 6:08 AM
AI InsightNo insight available
What's Moving KVACU Today?
No AI insight has been generated for KVACU yet. Check back soon — insights are generated from recent news analysis.
Generated Insights
No insights have been generated for KVACU yet. Check back soon.
KVACU News
6 articles- Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated CardiomyopathyYahoo Finance·Jul 15, 2025
- Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart SyndromeYahoo Finance·Jun 24, 2025
- Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025Yahoo Finance·Jun 13, 2025
- Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 CongressYahoo Finance·May 19, 2025
- Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 CongressYahoo Finance·May 12, 2025
- Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF SummitYahoo Finance·Apr 1, 2025
All 6 articles loaded
Price Data
Open—
Previous Close—
Day High—
Day Low—
52 Week High$11.50
52 Week Low$10.40
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-27.2%
Profit Margin—
Debt / Equity-1.01
Trading
Volume—
Avg Volume (10D)424
Shares Outstanding13.0M
About Keen Vision Acquisition Corporation Units
Keen Vision Acquisition Corp is a blank check company.
FinancialsBLANK CHECKS
Company Details
Security TypeUnit
ExchangeNASDAQ
CurrencyUSD
Round Lot100
SIC6770 — BLANK CHECKS
CIK0001889983
Composite FIGI—
Share Class FIGI—